• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE® CARDIOFORM ASD OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE® CARDIOFORM ASD OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER Back to Search Results
Catalog Number ASD48E
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Fever (1858); Thrombosis/Thrombus (4440)
Event Date 05/13/2022
Event Type  Injury  
Event Description
It was reported to gore that on (b)(6) 2022, a 48mm gore® cardioform asd occluder was selected to treat an atrial septal defect measuring 28-30mm (balloon sized) with a minimal aortic rim and posterior rim present about 5mm.The implantation was performed utilizing intracardiac echocardiography.A push and pull test showed the occluder after locking in a stable position and with no residual shunt.Post implantation, the patient reportedly suffered from high fever (40 degrees celsius) and chills.During multiple follow-up ultrasound examinations, the occluder device was found to be stable.On b)(6) 2022, both computed tomography and ultrasound imaging showed thrombus formation on the right disc and a residual shunt in the retro-aortal area.On (b)(6) 2022, the device was explanted due dislocation and an ongoing residual shunt.Reportedly, thrombus was also found on the left disc.During device implant, activated clotting time exceeded 240 seconds and a thrombolytic disorder is reportedly unknown.Following device explant, the physician surgically treated the defect.Post-operatively, it was reported that the patient was well.
 
Manufacturer Narrative
H6, health effect - clinical code: added imdrf code e230101.H6, component code: added imdrf codes g04088, g04027.H6, type of investigation: added imdrf codes b11, b20.H6, investigation conclusions: added imdrf code d12.Code c19 - the review of the manufacturing records verified that the lot involved in this event met all pre-release specifications.Histological findings of the explanted device as well as intra-operative images dated (b)(6) 2022, and post-operative images dated (b)(6) 2022 were requested from the physician via the reporting source.However, no additional information was received.With the information reported to gore this investigation is considered complete, the cause of the complaint was unable to be determined.Adverse events associated with the use of the septal occluders may include, but are not limited to: thrombosis or thromboembolic event resulting in clinical sequelae.H6, health effect - clinical code: replaced fda code 4440 with imdrf code e5014 h6, health effect - impact code: replaced fda codes 4625, 4627, with imdrf codes f1901, f12.H6, medical device problem code: replaced fda code 2993 with imdrf code a24.H6, type of investigation: replaced fda codes 3331, 4111, with imdrf codes b14, b13.H6, investigation findings: replaced fda code 213 with imdrf code c19.H6, investigation conclusions: replaced fda code 11 with imdrf code d15.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® CARDIOFORM ASD OCCLUDER
Type of Device
TRANSCATHETER SEPTAL OCCLUDER
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
KENDRICK PEAK MPD B/P
4250 w. kiltie lane
flagstaff AZ 86005
Manufacturer Contact
thomas giebing
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key14674553
MDR Text Key293837117
Report Number2017233-2022-03009
Device Sequence Number1
Product Code MLV
Combination Product (y/n)N
Reporter Country CodeSZ
PMA/PMN Number
P050006
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 04/03/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/13/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date04/11/2024
Device Catalogue NumberASD48E
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/23/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured04/13/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age39 YR
Patient SexMale
Patient Weight90 KG
-
-